Lenz Therapeutics (LT) Stock Price Target Cut to $48 by H.C. Wainwright
Published on Β· Source: investing.com
AI Summary
Summarized by AI from the source belowH.C. Wainwright has lowered the stock price target for Lenz Therapeutics (LT) to $48. This revision reflects adjustments in market expectations for the company's growth and profitability. Analysts often use price targets to indicate potential investment value and shifts in market sentiment toward a stock. The change in target could influence investor decisions, potentially impacting Lenz Therapeutics' trading volume and market position.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
